Skip to main content

Table 1 Outcomes of LVAD implantation in patients with left ventricular non-compaction

From: Left ventricular non-compaction cardiomyopathy and left ventricular assist device: a word of caution

  No. Patients Device Duration of support Complications Outcome
Maile et al., 2004 [4] 1 Male, 51 years DeBakey MicroMed LVAD 2.5 months None Successfully bridged to transplantation
Ivan et al., 2005 [6] 2 Male, 21 years Jarvik biventricular assist device Not indicated Not indicated Death before transplantation
   Male, 37 years Thoratec RVAD and
HeartMate LVAD
Not indicated Not indicated Death after transplantation
Nathan et al., 2010 [9] 1 Male, 14 years Abiomed, biventricular assist device 5 days None Successfully bridged to transplantation
Ninios et al., 2010 [5] 1 Male, 28 years Jarvik 2000 LV 3 years Recurrent thrombosis with successful intravenous lysis Patient on LVAD support at the date of publication
Hanke et al., 2012 [10] 1 Male, 12 months Berlin Heart, Excor, biventricular assist device 24 days Pulmonary haemorrhage requiring use of a membrane oxygenator, thrombosis requiring replacement of the LVAD Successfully bridged to transplantation
Siehr et al., 2013 [11] 1 Male, 6 weeks Berlin Heart, Excor, LVAD 56 days Embolic cerebrovascular accident, 2 pump exchanges due to clot formation Successfully bridged to transplantation
Uribarri et al., 2015 [7] 5 4 males (23, 25, 43,54 years)
1 female (24 years)
3 HVAD
2 HeartMate II
Mean follow up period 86.5 weeks, range 40–194 weeks 4 cases of pump thrombosis in 3 of 5 patients 2 deaths, 3 patients on LVAD support at the date of publication